SkinHuman RCT
OS-01: what the company-run skin trials show, and what they don't
Three small 12-week studies of the topical peptide OS-01 report better skin barrier and hydration. All were funded and authored by the company that owns it.
OS-01
A topical 'senotherapeutic' skin peptide; small 12-week human trials, all run by the company that owns it, report modest barrier and hydration gains.
- Also known as
- Peptide 14, Pep 14
- Area
- Skin
- Status
- Used as a cosmetic ingredient in topical skincare; not a licensed medicine